#digital-health-funding

#digital-health-funding

Cursor is nearing a funding round of at least $2 billion, with returning investors Thrive and Andreessen Horowitz expected to lead the financing at a $50 billion valuation. The deal terms are not final and may still change.

Joanna Strober recognized a business opportunity in women's health, particularly for menopausal women, and demonstrated grit and patience in securing investor support.

Online fitness coaching saves time by eliminating the need to commute to a gym. Workouts are accessible anytime and anywhere, allowing exercise to fit into your schedule.

Amazon Bio Discovery enables scientists to run complex computational workflows through more than 40 AI-specialized foundational models, trained on a wide range of biological datasets. These models generate and evaluate potential drug molecules, alongside AI agents that help scientists to select models, optimize inputs and evaluate candidates according to their research.

I hate to say it, but I would not have gone to the doctor unless I had seen that comment. The process was accelerated by someone called PickleFart, what can I say?

Bank of America raised its price target on Hims & Hers to $25 from $21, maintaining a Neutral rating. The FDA's procedural step to evaluate wellness peptides could open new revenue doors for the telehealth platform.

In March 2026, US startups raised $19.06 billion across 630 deals, a significant decline of 64.4% year-over-year from March 2025's $53.5 billion, which was heavily influenced by OpenAI's $40 billion mega-round.

Helical's thesis is that bio foundation models, AI systems trained on vast genomic, transcriptomic, and proteomic datasets, have already crossed a quality threshold that makes computational hypothesis-testing meaningful in pharma research.

The Covid-19 pandemic spurred a rapid expansion of health tech companies, and new market realities post pandemic meant it was only a matter of time before some consolidated. Indeed, investors in recent years predicted greater M&A activity only to never see it materialize either in 2024 or 2025. But 2026 may be the year the predictions do come true. Consider the deals announced in just over a month:

Between March 2020 and March 2022, over 100 million telemedicine services were delivered to approximately 17 million Australians. The Australian government invested $409 million to make telehealth permanent, whilst the UK announced £600 million for digital health infrastructure in April 2025. Patient adoption is equally impressive: 60% find telemedicine more convenient than in-person appointments, 55% report higher satisfaction with teleconsultations, and 74% of millennials prefer virtual appointments for routine care. These aren't temporary shifts; they represent a fundamental transformation in healthcare delivery.